Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CNSP
#5159
CNS Pharmaceuticals, Inc. Common Stock
2.7
5
USD
+4.17%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+4.17%
Monthly Change
+10.00%
6 month change
-71.11%
Year Change
+195.70%
Previous Close
2.6
4
Open
2.7
9
Bid
Ask
Low
2.6
8
High
2.8
9
Volume
38
Markets
US Stock Market
Healthcare
CNSP
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
245.37 K
455.16 K
574.58 K
620.29 K
811.45 K
—
Valuation ratios
Enterprise value
11.59 M
-5.41 M
-6.32 M
-4.25 M
-2.61 M
-18.59 M
Price to earnings ratio
-0.15
0
0
0
-0.15
-0.14
Price to sales ratio
12.11 K
—
—
—
-909.61
—
Price to cash flow ratio
-0.13
-0.01
-0.03
-0.04
-0.17
-0.24
Price to book ratio
0.37
-0
0.03
0.03
0.51
0.57
Enterprise value to EBITDA ratio
-0.78
0.34
0.41
0.32
0.16
1.24
Profitability ratios
Return on assets %
-0.37
-0.31
-0.16
-0.27
-0.69
-1.44
Return on equity %
-0.51
-0.39
-0.18
-0.32
-1.32
-2.21
Return on invested capital %
-6 082.74
—
—
—
-3 527.6
—
Gross margin %
—
—
—
—
100
—
Operating margin %
—
—
—
—
233.92 K
—
EBITDA margin %
—
—
—
—
233.98 K
—
Net margin %
—
—
—
—
232.74 K
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
3.43
4.94
10.22
5.81
1.98
22.95
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
-0
-0
Solvency ratios
Debt to assets ratio
0.04
0.02
0.01
0
0.04
0.06
Debt to equity ratio
0.05
0.02
0.01
0
0.07
0.1
Long term debt to total assets ratio
0.04
0.02
0.01
0
0.04
0.06
Long term debt to total equity ratio
0.05
0.02
0.01
0
0.07
0.1
Per share metrics
Operating cash flow per share
-171.75
-14.27
-14.44
-3.89
-6.88
-39.48
EBIT per share
-100.46
-19.09
-6.51
-5.82
-13.51
-44.93
EBITDA per share
-100.43
-19.09
-6.51
-5.82
-13.5
-44.92
Total debt per share
10.24
0.93
0.33
0.06
0.74
2.05
Cash per share
202.85
57.42
32.77
17.65
16.24
124.09
Net current asset value per share
271.82
60.39
38.2
20.38
18.28
137.25
Tangible book value per share
193.91
48.28
35.46
17.73
10.2
111.67
Working capital per share
192.58
48.16
34.46
16.88
9.03
108.52
Book value per share
193.91
48.28
35.46
17.73
10.2
111.67
News
CNS Pharmaceuticals shifts focus to neurology, oncology assets
CNS Pharmaceuticals names Lynne Kelley as chief medical officer
CNS Pharmaceuticals appoints three new executives to leadership team
CNS Pharmaceuticals’ new CEO outlines strategic overhaul
Corero Network Security reports DDoS protection platform enhancements
CNS Pharmaceuticals stock falls after CEO steps down
CNS Pharmaceuticals appoints Rami Levin as new CEO, replacing Climaco
CNS Pharmaceuticals shareholders approve share increases and board elections at annual meeting
CNS Pharmaceuticals, Inc. (CNSP) Shareholder/Analyst Call Prepared Remarks Transcript
Corero Network Security reports Q3 order intake growth
Upcoming Stock Splits This Week (July 21 to July 25) – Stay Invested - TipRanks.com
CNS Pharmaceuticals announces 1-for-12 reverse stock split